Skip to content

Clinical trials

Completed Phase 1 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 1 Status: Completed Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20081
20113
20121
20132
20141
20152
20171
20205
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Altor BioScience1
Aqualung Therapeutics Corp.1
Brigham and Women's Hospital1
Chiesi Farmaceutici S.p.A.1
Cynata Therapeutics Limited1
GlaxoSmithKline1
Gregory Yanik1
M.D. Anderson Cancer Center1
Mansoura University Children Hospital1
MiNK Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome20
Acute Lung Injury4
COVID-192
Hypoxia2
Sepsis2
Bronchiectasis1
Communicable Diseases1
Cystic Fibrosis1
Hemorrhagic Fever, Ebola1
Hypertension, Pulmonary1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.